glp-1 drugs heart failure keep getting more interesting… This new study suggests they may directly slow atherosclerosis and inflammation — even without weight loss or diabetes. ⚠️ But remember: animal data ≠ human outcomes Cardiologist: GLP1 Medications Reduce Heart

Howard Ave

Remember that ion exchange thing we covered back on the RC LiPo Battery Page

Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder

Sermorelin remains used in some dynamic GH stimulation tests in pediatric endocrinology, but this is a historical clinical use rather than a reference in preclinical research

FDA explains that a bulk drug substance used through the 503A pathway generally must meet one of the following conditions: Comply with an applicable United States Pharmacopeia or National Formulary monograph Be a component of a drug product with federal marketing authorization when no applicable monograph exists Appear on the 503A Bulks List when the first two pathways do not apply Additional requirements also apply, including documentation and sourcing requirements for the bulk drug substance

Yes, spotting between periods needs medical attention